Market Overview

Morphic Opens Above IPO Price


Morphic Holding, Inc. (NASDAQ: MORF) made its public debut Thursday morning, opening at $18 after being priced at $15 per share.

Jefferies, Cowen and Company, BMO Capital Markets and Wells Fargo are acting as joint book-running managers for the offering.

Morphic was founded in August 2014 and is a biopharma company developing a pipeline of oral small-molecule integrin therapeutics. Its Morphic integrin technology platform is used to develop novel product candidates designed to achieve the potency, high selectivity and pharmaceutical properties required for oral administration.

Invest in IPO shares before the stock hits the market with ClickIPO. Check it out here

The stock traded around $18.38 per share at time of publication.

Related Links:

Morphic Holding IPO: What You Need To Know

Adaptive Biotechnologies IPO: What You Need To Know

Posted-In: News IPOs


Related Articles (MORF)

View Comments and Join the Discussion!

Icahn To Occidental Petroleum: Kick Out 4 Board Members, Change Company Charter

Adaptive Biotechnologies Opens Above IPO Price